相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimized adaptive enrichment designs for three-arm trials: learning which subpopulations benefit from different treatments
Jon Arni Steingrimsson et al.
BIOSTATISTICS (2021)
An adaptive trial design to optimize dose-schedule regimes with delayed outcomes
Ruitao Lin et al.
BIOMETRICS (2020)
Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times
Juhee Lee et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2019)
Adaptive enrichment designs for confirmatory trials
Tze Leung Lai et al.
STATISTICS IN MEDICINE (2019)
A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III
Andrew G. Chapple et al.
BIOMETRICS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
LIBERTI: A SMART study in plastic surgery
Jonathan C. Hibbard et al.
CLINICAL TRIALS (2018)
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
Andrew G. Chapple et al.
PHARMACEUTICAL STATISTICS (2018)
Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support
Inbal Nahum-Shani et al.
ANNALS OF BEHAVIORAL MEDICINE (2018)
Using Bayesian modeling in frequentist adaptive enrichment designs
Noah Simon et al.
BIOSTATISTICS (2018)
Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding
F. Yan et al.
ANNALS OF ONCOLOGY (2018)
Subgroup selection in adaptive signature designs of confirmatory clinical trials
Zhiwei Zhang et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2017)
Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective
Xiaofei Bai et al.
LIFETIME DATA ANALYSIS (2017)
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials
Ilya Lipkovich et al.
STATISTICS IN MEDICINE (2017)
A simulation study of outcome adaptive randomization in multi-arm clinical trials
J. Kyle Wathen et al.
CLINICAL TRIALS (2017)
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
Thomas Ondra et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2016)
Multiple testing procedures for adaptive enrichment designs: combining group sequential and reallocation approaches
Michael Rosenblum et al.
BIOSTATISTICS (2016)
Comparison of Clustering Methods for High-Dimensional Single-Cell Flow and Mass Cytometry Data
Lukas M. Weber et al.
CYTOMETRY PART A (2016)
Bayesian inference for intratumour heterogeneity in mutations and copy number variation
Juhee Lee et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2016)
Subgroup-Based Adaptive (SUBA) Designs for Multi-arm Biomarker Trials
Yanxun Xu et al.
STATISTICS IN BIOSCIENCES (2016)
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials
P. Thall et al.
ANNALS OF ONCOLOGY (2015)
Are outcome-adaptive allocation trials ethical?
Spencer Phillips Hey et al.
CLINICAL TRIALS (2015)
MAD Bayes for Tumor Heterogeneity-Feature Allocation With Exponential Family Sampling
Yanxun Xu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2015)
Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity
Juhee Lee et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2015)
Adaptive enrichment designs for clinical trials
Noah Simon et al.
BIOSTATISTICS (2013)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Assessing the heterogeneity of treatment effects via potential outcomes of individual patients
Zhiwei Zhang et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2013)
Group sequential enrichment design incorporating subgroup selection
Baldur P. Magnusson et al.
STATISTICS IN MEDICINE (2013)
Bayesian Enrichment Strategies for Randomized Discontinuation Trials
Lorenzo Trippa et al.
BIOMETRICS (2012)
Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population
Li-Ling Hsieh et al.
CLINICA CHIMICA ACTA (2012)
ADAPTIVE RANDOMIZATION FOR CLINICAL TRIALS
William F. Rosenberger et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2012)
On the Usefulness of Outcome-Adaptive Randomization
Ying Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Subgroup identification from randomized clinical trial data
Jared C. Foster et al.
STATISTICS IN MEDICINE (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
The Cross-Validated Adaptive Signature Design
Boris Freidlin et al.
CLINICAL CANCER RESEARCH (2010)
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial
Nicholas D. James et al.
BJU INTERNATIONAL (2009)
Adaptive therapy for androgen-independent prostate cancer: A randomized selection trial of four regimens
Peter F. Thall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
Wenyu Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Practical Bayesian adaptive randomisation in clinical trials
Peter F. Thall et al.
EUROPEAN JOURNAL OF CANCER (2007)
Adaptive seamless designs: Selection and prospective testing of hypotheses
Christopher Jennison et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Evaluation of randomized discontinuation design
B Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments
PF Thall et al.
STATISTICS IN MEDICINE (2005)
An experimental design for the development of adaptive treatment strategies
SA Murphy
STATISTICS IN MEDICINE (2005)
Sequential designs for phase III clinical trials incorporating treatment selection
N Stallard et al.
STATISTICS IN MEDICINE (2003)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
分享论文
